Mar 07, 2025 17:40
CYBN - Cybin Inc.
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
6.38 -0.33 (-5.17%) | --- | --- | --- | -0.29 (-4.55%) | 0.02 (0.32%) | -0.12 (-1.94%) | -0.12 (-1.94%) |
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.
Earnings & Ratios
- Basic EPS:
- Diluted EPS:
- Basic P/E:
- Diluted P/E:
- RSI(14) 1m:
- 23.04
- VWAP:
- 6.05
- RVol:
- 0.5527
Events
Period | Kind | Movement | Occurred At |
---|---|---|---|
60m | Price decrease 60m | 6.02 -0.36 (-5.64%) | Oct 15 04:49 |
Related News
Jan 22, 2025 18:00
Sep 27, 2024 15:48
Jun 27, 2024 16:00
Jun 11, 2024 13:35
Jun 05, 2024 19:26
Mar 18, 2024 15:23
Jan 10, 2024 01:01
Nov 17, 2023 15:00
Nov 17, 2023 12:34